Sun Honghua, Li Yanglong, Quan Xianglan, Chen Ning, Jin Xinglin, Jin Wenbiao, Jin Yongmin, Shen Xionghu
Department of Oncology, Affiliated Hospital of Yanbian University Yanji, Jilin Province, People's Republic of China.
Department of Infection Disease, Affiliated Hospital of Yanbian University Yanji, Jilin Province, People's Republic of China.
Am J Transl Res. 2021 Nov 15;13(11):12395-12409. eCollection 2021.
The participation of STAT3 and its upstream inhibitors, PIAS3 and SOCS1, in the oxidative response of hepatocellular carcinoma (HCC) cells was uncertain. Here, the expression of PIAS3 and SOCS1 in HCC tissues and cell lines was explored, and we sought to determine whether oxidative stress epigenetically regulated PIAS3 and SOCS1 expression and STAT3 activation in HCC cells. The expression of PIAS3 and SOCS1 was markedly decreased in HCC cell lines and tissues compared to normal hepatic cells and tissues. In HCC patients, low PIAS3 and SOCS1 expression were associated with poor survival. Oxidative stress induced by HO in HepG2 cells was indicated by low antioxidant levels and high protein carbonyl content. Moreover, oxidative stress in HepG2 cells contributed to reduced proliferation but increased apoptosis, migration, and invasion capacity, which might be counteracted by antioxidants, such as tocopheryl acetate (TA). PIAS3 and SOCS1 expression was markedly decreased, while STAT3 was activated in HepG2 cells in response to HO exposure. Co-treatment with antioxidant TA effectively increased the expression of PIAS3 and SOCS1, but it dephosphorylated STAT3 in HO-treated cells. PIAS1 or SOCS1 overexpression in HepG2 cells after HO treatment restored cell viability and anti-oxidative responses and decreased apoptosis, migration, and invasion ability, and dephosphorylated STAT3 levels. Co-administration of the STAT3 activator, colivelin, partially abolished the effect of PIAS3 and SOCS1 overexpression in these processes. Therefore, oxidative stress in HCC cells may improve their migration and reduce proliferation through STAT3 activation through the repression of PIAS3 and SOCS1 expression.
信号转导和转录激活因子3(STAT3)及其上游抑制剂PIAS3和SOCS1在肝细胞癌(HCC)细胞氧化反应中的作用尚不确定。在此,我们探究了PIAS3和SOCS1在HCC组织和细胞系中的表达,并试图确定氧化应激是否通过表观遗传调控HCC细胞中PIAS3和SOCS1的表达以及STAT3的激活。与正常肝细胞和组织相比,PIAS3和SOCS1在HCC细胞系和组织中的表达明显降低。在HCC患者中,PIAS3和SOCS1低表达与较差的生存率相关。在HepG2细胞中,过氧化氢(HO)诱导的氧化应激表现为抗氧化水平降低和蛋白质羰基含量升高。此外,HepG2细胞中的氧化应激导致细胞增殖减少,但凋亡、迁移和侵袭能力增加,而抗氧化剂如醋酸生育酚(TA)可能会抵消这些作用。HO处理后,HepG2细胞中PIAS3和SOCS1表达明显降低,而STAT3被激活。抗氧化剂TA联合处理有效增加了PIAS3和SOCS1的表达,但使HO处理细胞中的STAT3去磷酸化。HO处理后HepG2细胞中PIAS1或SOCS1过表达可恢复细胞活力和抗氧化反应,降低凋亡、迁移和侵袭能力,并降低STAT3的磷酸化水平。同时给予STAT3激活剂colivelin可部分消除PIAS3和SOCS1过表达在这些过程中的作用。因此,HCC细胞中的氧化应激可能通过抑制PIAS3和SOCS1的表达激活STAT3,从而促进其迁移并减少增殖。